Posted at 07 Jun, 19:32h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Comments on Article in ‘The Atlantic,’ Highlighting the Second Pandemic of Addiction
Posted at 03 Jun, 19:33h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Announces Funding of Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share
Posted at 18 May, 19:33h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Featured on Multiple News Broadcasts Nationwide Regarding the Second Pandemic of Alcohol Use Disorder
Posted at 17 Mar, 16:02h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Founder and Chief Medical Officer Dr. Bankole Johnson Featured Guest on The Black News Channel
Posted at 17 Mar, 16:01h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Announces Management-Led $2,100,000 Above Market Private Placement at $3.00 Per Share
17 Mar Adial Schedules Town Hall to Discuss Positive Updates Regarding Pharmaceutical Pipeline and Business Expansion Posted at 16:00h in Press Release by adialpharma 0 Comments 0 Likes Share Read More
Posted at 23 Jan, 17:36h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Closes Acquisition of Purnovate
Posted at 23 Jan, 17:35h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals to Present at 23rd Annual ICR Conference
Posted at 11 Jan, 17:34h in Press Release by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Receives Notice of Allowance for Third U.S. Patent Covering AD04 for the Treatment for Opioid Use Disorder
Posted at 29 Sep, 13:56h in Press Release by adialpharma 0 Comments 2 Likes Share Adial Pharmaceuticals Announces COVID-19 Point-of-Care Antibody Test Granted First Ever FDA Emergency Use Authorization for Use with Fingerstick Blood Samples
